BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng X, Luyendyk JP, Ganey PE, Roth RA. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 2009;61:262-82. [PMID: 19805476 DOI: 10.1124/pr.109.001727] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Hadi M, Chen Y, Starokozhko V, Merema MT, Groothuis GM. Mouse Precision-Cut Liver Slices as an ex Vivo Model To Study Idiosyncratic Drug-Induced Liver Injury. Chem Res Toxicol 2012;25:1938-47. [DOI: 10.1021/tx300248j] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
2 Krueger W, Boelsterli UA, Rasmussen TP. Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury. J Clin Transl Hepatol. 2014;2:143-152. [PMID: 26355943 DOI: 10.14218/jcth.2014.00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Kuna L, Bozic I, Kizivat T, Bojanic K, Mrso M, Kralj E, Smolic R, Wu GY, Smolic M. Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives. Curr Drug Metab 2018;19:830-8. [PMID: 29788883 DOI: 10.2174/1389200219666180523095355] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
4 Rao T, Liu YT, Zeng XC, Li CP, Ou-Yang DS. The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury. Acta Pharmacol Sin. 2021;42:27-35. [PMID: 32123300 DOI: 10.1038/s41401-020-0360-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Selvaraj S, Oh JH, Spanel R, Länger F, Han HY, Lee EH, Yoon S, Borlak J. The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury. Oncotarget 2017;8:107763-824. [PMID: 29296203 DOI: 10.18632/oncotarget.21201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int J Mol Sci. 2017;18. [PMID: 28486401 DOI: 10.3390/ijms18051018] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 21.6] [Reference Citation Analysis]
7 Park BK, Laverty H, Srivastava A, Antoine DJ, Naisbitt D, Williams DP. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact. 2011;192:30-36. [PMID: 20846520 DOI: 10.1016/j.cbi.2010.09.011] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
8 Villanueva-Paz M, Niu H, Segovia-Zafra A, Medina-Caliz I, Sanabria-Cabrera J, Lucena MI, Andrade RJ, Alvarez-Alvarez I. Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions. J Clin Med 2021;10:5317. [PMID: 34830594 DOI: 10.3390/jcm10225317] [Reference Citation Analysis]
9 Gandhi A, Moorthy B, Ghose R. Drug disposition in pathophysiological conditions. Curr Drug Metab. 2012;13:1327-1344. [PMID: 22746301 DOI: 10.2174/138920012803341302] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
10 Cai M, Lin W. The Function of NF-Kappa B During Epilepsy, a Potential Therapeutic Target. Front Neurosci 2022;16:851394. [DOI: 10.3389/fnins.2022.851394] [Reference Citation Analysis]
11 Cullen JM, Faiola B, Melich DH, Peterson RA, Jordan HL, Kimbrough CL, Miller RT. Acute Alpha-Naphthylisothiocyanate-induced Liver Toxicity in Germfree and Conventional Male Rats. Toxicol Pathol 2016;44:987-97. [PMID: 27519817 DOI: 10.1177/0192623316662360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
12 Yu N, Di Q, Liu H, Hu Y, Jiang Y, Yan YK, Zhang YF, Zhang YD. Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure rats. Mediators Inflamm 2011;2011:670613. [PMID: 21403895 DOI: 10.1155/2011/670613] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
13 Roth RA, Maiuri AR, Ganey PE. Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin? J Pharmacol Exp Ther 2017;360:461-70. [PMID: 28104833 DOI: 10.1124/jpet.116.237578] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
14 Selvaraj S, Oh JH, Borlak J. An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac. Arch Toxicol 2020;94:2733-48. [PMID: 32372211 DOI: 10.1007/s00204-020-02767-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shaw PJ, Ganey PE, Roth RA. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci 2010;118:7-18. [PMID: 20538741 DOI: 10.1093/toxsci/kfq168] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
16 Heidari R, Ahmadi F, Rahimi HR, Azarpira N, Hosseinzadeh M, Najibi A, Niknahad H. Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice. Drug Chem Toxicol 2019;42:615-23. [PMID: 29722569 DOI: 10.1080/01480545.2018.1459668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ. Eicosanoids in metabolic syndrome. Adv Pharmacol 2013;66:157-266. [PMID: 23433458 DOI: 10.1016/B978-0-12-404717-4.00005-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
18 Shojaie L, Ali M, Iorga A, Dara L. Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta Pharmaceutica Sinica B 2021;11:3727-39. [DOI: 10.1016/j.apsb.2021.10.003] [Reference Citation Analysis]
19 Devarbhavi H. An Update on Drug-induced Liver Injury. J Clin Exp Hepatol. 2012;2:247-259. [PMID: 25755441 DOI: 10.1016/j.jceh.2012.05.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
20 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S. Current challenges and controversies in drug-induced liver injury. Drug Saf. 2012;35:1099-1117. [PMID: 23137150 DOI: 10.2165/11632970-000000000-00000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Toyoda Y, Endo S, Tsuneyama K, Miyashita T, Yano A, Fukami T, Nakajima M, Yokoi T. Mechanism of exacerbative effect of progesterone on drug-induced liver injury. Toxicol Sci 2012;126:16-27. [PMID: 22157104 DOI: 10.1093/toxsci/kfr326] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
22 Granitzny A, Knebel J, Müller M, Braun A, Steinberg P, Dasenbrock C, Hansen T. Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study. Toxicol Rep 2017;4:89-103. [PMID: 28959630 DOI: 10.1016/j.toxrep.2017.02.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Niknahad H, Heidari R, Firuzi R, Abazari F, Ramezani M, Azarpira N, Hosseinzadeh M, Najibi A, Saeedi A. Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats. Adv Pharm Bull. 2016;6:617-625. [PMID: 28101469 DOI: 10.15171/apb.2016.076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kuyucu S, Caubet J. Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects. The Journal of Allergy and Clinical Immunology: In Practice 2018;6:1879-1891.e1. [DOI: 10.1016/j.jaip.2018.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M. Current Challenges and Controversies in Drug-Induced Liver Injury. Drug Saf 2012;35:1099-117. [DOI: 10.1007/bf03261997] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
26 Hassan HM, Guo H, Yousef BA, Ping-Ping D, Zhang L, Jiang Z. Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress. Front Pharmacol 2017;8:133. [PMID: 28360859 DOI: 10.3389/fphar.2017.00133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hassan HM, Guo H, Yousef BA, Guerram M, Hamdi AM, Zhang L, Jiang Z. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment. Antimicrob Agents Chemother 2016;60:5285-93. [PMID: 27324775 DOI: 10.1128/AAC.00854-16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
28 Yoshikado T, Takada T, Yamamoto H, Tan JK, Ito K, Santa T, Suzuki H. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites. Mol Pharmacol 2013;83:552-62. [DOI: 10.1124/mol.112.081752] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
29 Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315-530. [PMID: 23974980 DOI: 10.1007/s00204-013-1078-5] [Cited by in Crossref: 751] [Cited by in F6Publishing: 687] [Article Influence: 83.4] [Reference Citation Analysis]
30 Mir TM, Ma G, Ali Z, Khan IA, Ashfaq MK. Effect of Raspberry Ketone on Normal, Obese and Health-Compromised Obese Mice: A Preliminary Study. J Diet Suppl 2021;18:1-16. [PMID: 31603036 DOI: 10.1080/19390211.2019.1674996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Lee EH, Oh JH, Selvaraj S, Park SM, Choi MS, Spanel R, Yoon S, Borlak J. Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice. Oncotarget 2016;7:14983-5017. [PMID: 26934552 DOI: 10.18632/oncotarget.7698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
32 Roth RA, Ganey PE. Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one? J Pharmacol Exp Ther. 2010;332:692-697. [PMID: 20019161 DOI: 10.1124/jpet.109.162651] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 7.6] [Reference Citation Analysis]
33 Wu X, Zhang Y, Qiu J, Xu Y, Zhang J, Huang J, Bai J, Huang Z, Qiu X, Xu W. Lipidomics Analysis Indicates Disturbed Hepatocellular Lipid Metabolism in Reynoutria multiflora-Induced Idiosyncratic Liver Injury. Front Pharmacol 2020;11:569144. [PMID: 33408629 DOI: 10.3389/fphar.2020.569144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mizuno K, Fukami T, Toyoda Y, Nakajima M, Yokoi T. Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathway. Life Sci 2010;87:537-44. [PMID: 20816994 DOI: 10.1016/j.lfs.2010.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
35 Li X, Wang Z, Zou Y, Lu E, Duan J, Yang H, Wu Q, Zhao X, Wang Y, You L, He L, Xi T, Yang Y. Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization. Immunol Res 2015;62:137-45. [PMID: 25846584 DOI: 10.1007/s12026-015-8644-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
36 Wu W, Zhao L, Yang P, Zhou W, Li B, Moorhead JF, Varghese Z, Ruan XZ, Chen Y. Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice. PLoS One 2016;11:e0159512. [PMID: 27428373 DOI: 10.1371/journal.pone.0159512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
37 Hughes TB, Dang NL, Kumar A, Flynn NR, Swamidass SJ. Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites. J Chem Inf Model 2020;60:4702-16. [DOI: 10.1021/acs.jcim.0c00360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Saab L, Peluso J, Muller CD, Ubeaud-sequier G. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry. Cytometry 2013;83A:403-8. [DOI: 10.1002/cyto.a.22263] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
39 Pan Y, Cao M, You D, Qin G, Liu Z. Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives. Biomed Res Int 2019;2019:1283824. [PMID: 31119149 DOI: 10.1155/2019/1283824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Liguori MJ, Ditewig AC, Maddox JF, Luyendyk JP, Lehman-McKeeman LD, Nelson DM, Bhaskaran VM, Waring JF, Ganey PE, Roth RA, Blomme EA. Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example. Int J Mol Sci 2010;11:4697-714. [PMID: 21151465 DOI: 10.3390/ijms11114697] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
41 Cosgrove BD, Alexopoulos LG, Hang TC, Hendriks BS, Sorger PK, Griffith LG, Lauffenburger DA. Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst. 2010;6:1195-1206. [PMID: 20361094 DOI: 10.1039/b926287c] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
42 Cichocki JA, Furuya S, Luo YS, Iwata Y, Konganti K, Chiu WA, Threadgill DW, Pogribny IP, Rusyn I. Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice. Toxicol Sci 2017;159:102-13. [PMID: 28903486 DOI: 10.1093/toxsci/kfx120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
43 Delgado A, Stewart S, Urroz M, Rodríguez A, Borobia AM, Akatbach-Bousaid I, González-Muñoz M, Ramírez E. Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. J Clin Med 2021;10:4432. [PMID: 34640458 DOI: 10.3390/jcm10194432] [Reference Citation Analysis]
44 Shim K, Kim D, Song S, Qi X, Yoon Y, Kim H, Lee J, Oh H, Kim S, Lee K. Hepatoprotection of different water extracts from Acer tegmentosum M. on CCl4-induced acute hepatotoxicity in mice: comparative efficacies between the extracts of boughs, twigs, and leaves. Mol Cell Toxicol 2011;7:405-13. [DOI: 10.1007/s13273-011-0051-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Ommati MM, Mobasheri A, Heidari R. Drug-induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies. J Biochem Mol Toxicol 2021;35:e22795. [PMID: 33973313 DOI: 10.1002/jbt.22795] [Reference Citation Analysis]
46 Mizuno K, Toyoda Y, Fukami T, Nakajima M, Yokoi T. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway. Arch Toxicol 2011;85:199-207. [DOI: 10.1007/s00204-010-0584-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
47 Moggs J, Moulin P, Pognan F, Brees D, Leonard M, Busch S, Cordier A, Heard DJ, Kammüller M, Merz M, Bouchard P, Chibout S. Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology 2012;8:1071-82. [DOI: 10.1517/17425255.2012.693914] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
48 Hassan HM, Yousef BA, Guo H, Xiaoxin L, Zhang L, Jiang Z. Investigating the CYP2E1 Potential Role in the Mechanisms Behind INH/LPS-Induced Hepatotoxicity. Front Pharmacol 2018;9:198. [PMID: 29563874 DOI: 10.3389/fphar.2018.00198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ramm S, Mally A. Role of drug-independent stress factors in liver injury associated with diclofenac intake. Toxicology 2013;312:83-96. [PMID: 23939143 DOI: 10.1016/j.tox.2013.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
50 Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol. 2013;26:710-720. [PMID: 23565644 DOI: 10.1021/tx300519p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
51 Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol 2011;7:e1002310. [PMID: 22194678 DOI: 10.1371/journal.pcbi.1002310] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
52 Li CY, Tu C, Gao D, Wang RL, Zhang HZ, Niu M, Li RY, Zhang CE, Li RS, Xiao XH, Yang MH, Wang JB. Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis. Front Pharmacol 2016;7:483. [PMID: 28018221 DOI: 10.3389/fphar.2016.00483] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
53 Ramm S, Morissey B, Hernandez B, Rooney C, Pennington SR, Mally A. Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration. Toxicology 2015;331:100-11. [PMID: 25772430 DOI: 10.1016/j.tox.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
54 Wang Y, Gao LN, Cui YL, Jiang HL. Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Evid Based Complement Alternat Med 2014;2014:153902. [PMID: 24772178 DOI: 10.1155/2014/153902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
55 Meyer MJ, Seitz T, Brockmöller J, Tzvetkov MV. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. PLoS One 2017;12:e0189521. [PMID: 29236753 DOI: 10.1371/journal.pone.0189521] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
56 Chen WLK, Edington C, Suter E, Yu J, Velazquez JJ, Velazquez JG, Shockley M, Large EM, Venkataramanan R, Hughes DJ, Stokes CL, Trumper DL, Carrier RL, Cirit M, Griffith LG, Lauffenburger DA. Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk. Biotechnol Bioeng 2017;114:2648-59. [PMID: 28667746 DOI: 10.1002/bit.26370] [Cited by in Crossref: 93] [Cited by in F6Publishing: 75] [Article Influence: 18.6] [Reference Citation Analysis]
57 Tu C, Gao D, Li XF, Li CY, Li RS, Zhao YL, Li N, Jia GL, Pang JY, Cui HR, Ma ZJ, Xiao XH, Wang JB. Inflammatory stress potentiates emodin-induced liver injury in rats. Front Pharmacol 2015;6:233. [PMID: 26557087 DOI: 10.3389/fphar.2015.00233] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
58 Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115:307-321. [PMID: 20071422 DOI: 10.1093/toxsci/kfq009] [Cited by in Crossref: 201] [Cited by in F6Publishing: 177] [Article Influence: 16.8] [Reference Citation Analysis]
59 Bandeira ACB, da Silva RC, Rossoni JV Júnior, Figueiredo VP, Talvani A, Cangussú SD, Bezerra FS, Costa DC. Lycopene pretreatment improves hepatotoxicity induced by acetaminophen in C57BL/6 mice. Bioorg Med Chem 2017;25:1057-65. [PMID: 28031152 DOI: 10.1016/j.bmc.2016.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
60 Dugan CM, MacDonald AE, Roth RA, Ganey PE. A mouse model of severe halothane hepatitis based on human risk factors. J Pharmacol Exp Ther 2010;333:364-72. [PMID: 20124411 DOI: 10.1124/jpet.109.164541] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
61 Roth RA, Ganey PE. Role of Inflammation in Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 157-73. [DOI: 10.1016/b978-0-12-387817-5.00010-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
62 Yu N, Di Q, Hu Y, Zhang Y, Su L, Liu X, Li L. A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure. Neuroscience Letters 2012;514:110-5. [DOI: 10.1016/j.neulet.2012.02.070] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
63 Ahn JH, Jegal H, Choi MS, Kim S, Park SM, Ahn J, Han HY, Cho HS, Yoon S, Oh JH. TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy. Toxicol Lett 2021;342:73-84. [PMID: 33609687 DOI: 10.1016/j.toxlet.2021.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Kwast L, Fiechter D, Kruijssen L, Bleumink R, Ludwig I, Bol-Schoenmakers M, Smit J, Pieters R. Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen. J Immunotoxicol 2016;13:535-47. [PMID: 27043250 DOI: 10.3109/1547691X.2016.1139643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Dara L, Kaplowitz N. Drug‐Induced Liver Injury. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 701-13. [DOI: 10.1002/9781119436812.ch54] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
66 Su Y, Zhang Y, Chen M, Jiang Z, Sun L, Wang T, Zhang L. Lipopolysaccharide exposure augments isoniazide-induced liver injury. J Appl Toxicol 2014;34:1436-42. [PMID: 25331106 DOI: 10.1002/jat.2979] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
67 Jiang J, Mathijs K, Timmermans L, Claessen SM, Hecka A, Weusten J, Peters R, van Delft JH, Kleinjans JCS, Jennen DGJ. Omics-based identification of the combined effects of idiosyncratic drugs and inflammatory cytokines on the development of drug-induced liver injury. Toxicol Appl Pharmacol. 2017;332:100-108. [PMID: 28733206 DOI: 10.1016/j.taap.2017.07.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
68 Hughes TB, Flynn N, Dang NL, Swamidass SJ. Modeling the Bioactivation and Subsequent Reactivity of Drugs. Chem Res Toxicol 2021;34:584-600. [PMID: 33496184 DOI: 10.1021/acs.chemrestox.0c00417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Baillie TA, Rettie AE. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 2011;26:15-29. [PMID: 20978360 DOI: 10.2133/dmpk.dmpk-10-rv-089] [Cited by in Crossref: 72] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
70 Oppelt A, Kaschek D, Huppelschoten S, Sison-Young R, Zhang F, Buck-Wiese M, Herrmann F, Malkusch S, Krüger CL, Meub M, Merkt B, Zimmermann L, Schofield A, Jones RP, Malik H, Schilling M, Heilemann M, van de Water B, Goldring CE, Park BK, Timmer J, Klingmüller U. Model-based identification of TNFα-induced IKKβ-mediated and IκBα-mediated regulation of NFκB signal transduction as a tool to quantify the impact of drug-induced liver injury compounds. NPJ Syst Biol Appl 2018;4:23. [PMID: 29900006 DOI: 10.1038/s41540-018-0058-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
71 Gao D, Pang JY, Zhang CE, Li CY, Tu C, Zhang HZ, Niu M, Xiong Y, Xiao XH, Zhao KJ, Gao WW, Wang JB. Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata. Front Pharmacol 2016;7:386. [PMID: 27803670 DOI: 10.3389/fphar.2016.00386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
72 Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, Wang C, Geng X, Li B. Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: Inflammatory and oxidative stress playing important roles. Journal of Ethnopharmacology 2019;239:111910. [DOI: 10.1016/j.jep.2019.111910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
73 Stagg NJ, Ghantous HN, Roth R, Hastings KL. Predictivity/Translatability of Toxicities Observed in Nonclinical Toxicology Studies to Clinical Safety Outcomes in Drug Development: Case Examples. Int J Toxicol 2020;39:141-50. [PMID: 31875744 DOI: 10.1177/1091581819894281] [Reference Citation Analysis]
74 Ng W, Lobach AR, Zhu X, Chen X, Liu F, Metushi IG, Sharma A, Li J, Cai P, Ip J, Novalen M, Popovic M, Zhang X, Tanino T, Nakagawa T, Li Y, Uetrecht J. Animal Models of Idiosyncratic Drug Reactions. Current Concepts in Drug Metabolism and Toxicology. Elsevier; 2012. pp. 81-135. [DOI: 10.1016/b978-0-12-398339-8.00003-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
75 Obogwu MB, Akindele AJ, Adeyemi OO. Hepatoprotective and in vivo antioxidant activities of the hydroethanolic leaf extract of Mucuna pruriens (Fabaceae) in antitubercular drugs and alcohol models. Chin J Nat Med 2014;12:273-83. [PMID: 24863352 DOI: 10.1016/S1875-5364(14)60054-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
76 Sarkar U, Rivera-Burgos D, Large EM, Hughes DJ, Ravindra KC, Dyer RL, Ebrahimkhani MR, Wishnok JS, Griffith LG, Tannenbaum SR. Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab Dispos. 2015;43:1091-1099. [PMID: 25926431 DOI: 10.1124/dmd.115.063495] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
77 Li F, Cao L, Parikh S, Zuo R. Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury. J Pharm Sci 2020;109:1912-23. [PMID: 32145211 DOI: 10.1016/j.xphs.2020.02.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
78 Cai Q, Wei J, Zhao W, Shi S, Zhang Y, Wei R, Zhang Y, Li W, Wang Q. Toxicity of Evodiae fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. Molecules. 2014;19:21168-21182. [PMID: 25521117 DOI: 10.3390/molecules191221168] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
79 Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 2011;71:701-7. [PMID: 21480949 DOI: 10.1111/j.1365-2125.2010.03764.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
80 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
81 Boelsterli UA. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 343-67. [DOI: 10.1016/b978-0-12-387817-5.00021-2] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
82 Luyendyk J, Roth R, Ganey P. Inflammation and Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 295-317. [DOI: 10.1016/b978-0-08-046884-6.01031-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Roth RA, Ganey PE. Animal models of idiosyncratic drug-induced liver injury—Current status. Critical Reviews in Toxicology 2011;41:723-39. [DOI: 10.3109/10408444.2011.575765] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
84 Luyendyk JP, Mackman N, Sullivan BP. Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury. Toxicol Sci 2011;119:233-43. [PMID: 20974703 DOI: 10.1093/toxsci/kfq327] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
85 Rohilla R, Garg T, Goyal AK, Rath G. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Delivery 2016. [DOI: 10.3109/10717544.2014.945018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]